Efficacy and safety of interferon alfa-2b and ribavirin combination therapy in chronic hepatitis C patients: A Czech multicenter study

被引：0
|
作者：
Husa, P
Krtek, V
Svejda, J
Stransky, J
Cieslarova, B
Nadvornik, V
Ehrmann, J
Urbanek, P
Volfova, M
机构：
[1] Teaching Hosp, Brno, Czech Republic
[2] Teaching Hosp, Krc, Czech Republic
[3] Private Doctors Assoc, Usti Nad Labem, Czech Republic
[4] Teaching Hosp Kralovske Vinohadry, Prague, Czech Republic
[5] Mil Hosp, Prague, Czech Republic
[6] Teaching Hosp, Olomouc, Czech Republic
[7] Teaching Hosp Praha 2, Prague, Czech Republic
[8] Teaching Hosp, Hradec Kralove, Czech Republic
来源：
JOURNAL OF HEPATOLOGY | 2002年 / 36卷
关键词：
D O I：
10.1016/S0168-8278(02)80849-2
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
848
引用
收藏
页码：237 / 237
页数：1
相关论文
共 50 条
  • [41] Efficacy of pegylated interferon alfa-2a or alfa-2b in combination with ribavirin in the treatment of chronic hepatitis caused by hepatitis C virus genotype 1b
    Mach, Tomasz H.
    Ciesla, Andrzej
    Warunek, Wioleta
    Janas-Skulina, Urszula
    Cibor, Dorota
    Owczarek, Danuta
    Ciecko-Michalska, Irena
    POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ-POLISH ARCHIVES OF INTERNAL MEDICINE, 2011, 121 (12): : 434 - 439
  • [42] Treatment with combination peginterferon alfa-2b and ribavirin of recurrent hepatitis C in liver transplant recipients nonresponsive to interferon alfa-2b and ribavirin
    Samanta, A
    Mandalapu, A
    Fisher, A
    Wilson, D
    de la Torre, A
    Klein, KM
    Koneru, B
    GASTROENTEROLOGY, 2005, 128 (04) : A455 - A456
  • [43] Interferon alfa-2b therapy for chronic hepatitis
    Kirchner, JT
    AMERICAN FAMILY PHYSICIAN, 1997, 55 (07) : 2434 - 2434
  • [44] Adverse cutaneous reactions to interferon alfa-2b plus ribavirin therapy in patients with chronic hepatitis C virus
    Manjón-Haces, JA
    Vázquez-López, F
    Gómez-Díez, S
    Hidalgo-García, Y
    Pérez-Alvarez, R
    Soler-Sánchez, T
    Pérez-Oliva, N
    ACTA DERMATO-VENEREOLOGICA, 2001, 81 (03) : 223 - 223
  • [45] Pegylated interferon alfa-2b plus ribavirin for treatment of chronic hepatitis C
    PN Rao
    Abraham Koshy
    Jacob Philip
    Narayanan Premaletha
    Joy Varghese
    Krishnasamy Narayanasamy
    Samir Mohindra
    Nitin Vikas Pai
    Manoj Kumar Agarwal
    Ashokna Konar
    Hasmukh B Vora
    World Journal of Hepatology, 2014, (07) : 520 - 526
  • [46] Pegylated interferon alfa-2b plus ribavirin for treatment of chronic hepatitis C
    Rao, P. N.
    Koshy, Abraham
    Philip, Jacob
    Premaletha, Narayanan
    Varghese, Joy
    Narayanasamy, Krishnasamy
    Mohindra, Samir
    Pai, Nitin Vikas
    Agarwal, Manoj Kumar
    Konar, Ashoknanda
    Vora, Hasmukh B.
    WORLD JOURNAL OF HEPATOLOGY, 2014, 6 (07) : 520 - 526
  • [47] SUPPRESSIVE EFFECT OF PEGYLATED INTERFERON ALFA-2B PLUS RIBAVIRIN COMBINATION THERAPY ON INCIDENCE OF HEPATOCELLLULAR CARCINOMA IN PATIENTS WITH CHRONIC HEPATITIS C
    Oze, Tsugiko
    Hiramatsu, Naoki
    Yakushijin, Takayuki
    Mochizuki, Kiyoshi
    Oshita, Masahide
    Hagiwara, Hideki
    Mita, Eiji
    Fukui, Hiroyuki
    Inui, Yoshiaki
    Hijioka, Taizo
    Inada, Masami
    Tamura, Shinji
    Yoshihara, Harumasa
    Inoue, Atsuo
    Imai, Yasuharu
    Kato, Michio
    Hosui, Atsushi
    Miyagi, Takuya
    Yoshida, Yuichi
    Tatsumi, Tomohide
    Kiso, Shinichi
    Kanto, Tatsuya
    Kasahara, Akinori
    Takehara, Tetsuo
    Hayashi, Norio
    HEPATOLOGY, 2010, 52 (04) : 769A - 769A
  • [48] Impact of pegylated interferon alfa-2b and ribavirin on liver fibrosis in patients with chronic hepatitis C
    Poynard, T
    McHutchison, J
    Manns, M
    Trepo, C
    Lindsay, K
    Goodman, Z
    Ling, MH
    Albrecht, J
    GASTROENTEROLOGY, 2002, 122 (05) : 1303 - 1313
  • [49] Long term interferon alfa-2B therapy in chronic hepatitis B. Multicenter study
    Lengyel, G
    Feher, J
    Dalmi, L
    David, K
    Gervain, J
    Gogl, A
    Lonovics, J
    Ozsvar, Z
    Par, A
    Schneider, F
    Tulassay, Z
    HEPATOLOGY, 1996, 23 (01) : P158 - P158
  • [50] Impact of interferon alfa-2b and ribavirin on progression of liver fibrosis in patients with chronic hepatitis C
    Poynard, T
    McHutchison, J
    Davis, GL
    Esteban-Mur, R
    Goodman, Z
    Bedossa, P
    Albrecht, J
    HEPATOLOGY, 2000, 32 (05) : 1131 - 1137
12345